Two frameworks, one operational environment
Clinical research organisations rarely start from a blank page when developing a GDPR framework. Sponsors and CROs already work within established quality systems, documented responsibilities, controlled processes and oversight arrangements. Good Clinical Practice (GCP) provides much of that operational discipline. The opportunity is to build data protection into this environment rather than create a second system beside it.
GCP and GDPR protect different rights of the same individual. GCP safeguards the rights, safety and well-being of clinical trial participants, while GDPR protects their rights and freedoms in relation to the processing of personal data. Although their objectives differ, the two frameworks converge in many of the organisational and technical measures required to protect those rights. Clear responsibilities, risk management, documented procedures, access controls, training and effective oversight can serve both frameworks, allowing organisations to build on existing GCP processes when addressing GDPR requirements.
Start with what already works
Consider an established process for qualifying trial vendors. It may already capture supplier assessments, service descriptions, training and performance monitoring. Rather than inventing a separate privacy approval route, organisations can add the questions needed to address processing roles, access to personal data, security arrangements, subcontractors and international transfers.
The same principle applies to document control, change management, incident management and inspection readiness. Existing systems can provide an operational home for privacy requirements, provided any gaps are identified and addressed deliberately.
Where additional work is needed
A robust GCP system does not by itself establish a GDPR lawful basis, satisfy transparency obligations, define controller and processor roles or provide a legal mechanism for international transfers. Nor does a quality risk assessment automatically replace a data protection impact assessment (DPIA), which considers risks to individuals' rights and freedoms.
The useful question is therefore not whether GCP makes GDPR unnecessary. It is which existing controls can be relied on, what evidence supports that reliance, and which privacy-specific decisions still need to be made.
A proportionate starting point
Map the personal data and processing activities involved in the study or organisation. Identify the processes and controls already operating under GCP and the quality management system. Assess them against GDPR requirements, assign ownership for any gaps and record how compliance will be maintained as studies, systems and vendors change.
This approach makes privacy compliance easier to operate and easier to demonstrate. The objective is not less accountability; it is a single, coherent operating model in which data protection is part of how clinical research is conducted.
Key references: GDPR Articles 5, 24, 25, 28, 30, 32 and 35; ICH E6(R3) Principles and Annex 1.